FDA Adverse Event Injury Summary report: N

CM DRIVE IMPLANT 4.3X8

MDR report key: 7028889 · Received November 14, 2017

Report

Report Number
3008261720-2017-04819
Event Type
Injury
Date Received
November 14, 2017
Date of Event
August 17, 2017
Report Date
November 14, 2017
Manufacturer
NEODENT - JJGC S.A.
Product Code
DZE
UDI-DI
07898237569314
PMA / PMN Number
K123022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
DENTIST

Narratives

Additional Manufacturer Narrative · 0

EXEMPTION NUMBER: E2015015. INSTRADENT USA, INC IS SUBMITTING THE REPORT ON BEHALF OF NEODENT - JJGC. AFTER THE EVALUATION PERFORMED BY THE MANUFACTURER, IT WAS NOTICED THAT THE ITEM RECIEVED IS DIFERENT FROM THE ITEM FIRST REPORTED.

Additional Manufacturer Narrative · 0

EXEMPTION NUMBER: E2015015. INSTRADENT USA, INC IS SUBMITTING THE REPORT ON BEHALF OF NEODENT - JJGC.

Description of Event or Problem · 0

THE CLINICIAN REPORTED THAT 11 MONTHS AFTER THE DENTAL IMPLANT WAS PLACED IN SITE ADA #20 OF PATIENT'S MOUTH, A LOSS OF OSSEOINTEGRATION WAS OBSERVED. THE PATIENT'S BONE QUALITY WAS REPORTED TO BE TYPE II. THE CLINICIAN REPORTED OCCLUSAL TRAUMA, BIOMECHANICAL OVERLOAD, IMMEDIATE LOAD AND PERIMPLANTITIS TO HAVE INFLUENCED THE PROBLEM. THIS DEVICE WILL BE FORWARDED TO THE MANUFACTURER FOR INVESTIGATION. THERE WERE NO REPORTED COMPLICATIONS.

Description of Event or Problem · 0

THE CLINICIAN REPORTED THAT 11 MONTHS AFTER THE DENTAL IMPLANT WAS PLACED IN SITE ADA #20 OF PATIENT'S MOUTH, A LOSS OF OSSEOINTEGRATION WAS OBSERVED. THE PATIENT'S BONE QUALITY WAS REPORTED TO BE TYPE II. THE CLINICIAN REPORTED OCCUSAL TRAUMA, BIOMECHANICAL OVERLOAD, IMMEDIATE LOAD AND PERIMPLANTITIS TO HAVE INFLUENCED THE PROBLEM. THIS DEVICE WILL BE FORWARDED TO THE MANUFACTURER FOR INVESTIGATION. THERE WERE NO REPORTED COMPLICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
807068 CM DRIVE IMPLANT 4.3X8 ENDOSSEOUS DENTAL IMPLANT DZE NEODENT - JJGC S.A. 32657I 07898237569314

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention